Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07413653
Recruiting
Virtual hIStology of Crohn's Disease Ex-vivo Resected Anatomical Lesions
Not applicable · France · 1 site
Registry update: 21 Oct 2026
2025-521164-36-00
Recruiting
A phase 1/2a, first-in-human, open-label, dose-escalating study with a safety expansion cohort to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary anti-tumour activity of TAX2 in patients with relapsed/refractory advanced/metastatic solid tumours
Phase 1/2 · Belgium, France · 4 sites
Registry update: 1 Jul 2026
NCT07142278
Recruiting
DUVAX: A Phase 1 Alzheimer's Vaccine Study Targeting Amyloid-Beta and Tau
Phase 1 · United States · 1 site
Registry update: 30 Sept 2026
NCT07444606
Recruiting
Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases
Phase 1 · United States · 1 site
Registry update: 2 Nov 2026
NCT07437950
Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Phase 2 · Puerto Rico, United States · 64 sites
Registry update: 6 Nov 2026
NCT07817875
Recruiting
Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
Phase 3 · Belgium, Spain, Israel, Italy, South Korea, Mexico, Poland, Portugal, Taiwan, United States · 82 sites
Registry update: 4 Nov 2026
NCT07705607
Recruiting
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-005)
Phase 3 · United States · 20 sites
Registry update: 3 Nov 2026
NCT07840508
Recruiting
Velocity-Loss Training and Parkinson's Disease
Not applicable · United States · 1 site
Registry update: 28 Sept 2026
NCT07437313
Recruiting
Marine Lipids Ease Painful TMD
Not applicable · United States · 1 site
Registry update: 5 Nov 2026
2026-525260-18-00
Recruiting
Use of Indipamide to reduce progression of disability in people with primary and secondary progressive multiple sclerosis (MS).
Phase 2 · Netherlands · 1 site
Registry update: 8 Jul 2026
NCT07704099
Recruiting
Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy
Phase 2 · Georgia, New Zealand · 4 sites
Registry update: 4 Nov 2026
NCT07723482
Recruiting
ML-016 in Advanced Cancer With Lung and/or Liver Involvement
Phase 1/2 · Australia · 3 sites
Registry update: 5 Oct 2026
NCT07783282
Recruiting
A Study to Learn How Enzalutamide, Apalutamide and Bicalutamide Affect the Way Fezolinetant is Processed in Men With Prostate Cancer
Phase 1 · Bulgaria · 1 site
Registry update: 16 Oct 2026
NCT07842341
Recruiting
MH-Rx Study (Baby on Board: Check-in on You, Your Medication, & Your Blood Pressure)
Not applicable · United States · 1 site
Registry update: 14 Oct 2026
NCT07763210
Recruiting
Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma
Phase 2 · United States · 1 site
Registry update: 2 Oct 2026
NCT07821450
Recruiting
Blepharoptosis After Repeated Intravitreal Anti-VEGF Injections: A Prospective Study
Not applicable · 1 site
Registry update: 2 Nov 2026
NCT07872553
Recruiting
A Study of Treatment Delivery Preference In People With Kidney Cancer
Phase 4 · United States · 7 sites
Registry update: 16 Oct 2026
NCT07897071
Recruiting
AXT-1003 Combination With Enzalutamide in Participants With mCRPC
Phase 1 · China · 4 sites
Registry update: 27 Oct 2026
NCT07649265
Recruiting
A Trial in Healthy Adult Participants and Adults With Autoimmune Diseases to Test How HBM7020 is Tolerated and How it Behaves in the Body
Phase 1 · Australia · 1 site
Registry update: 5 Nov 2026
NCT07641361
Recruiting
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Not applicable · United States · 1 site
Registry update: 2 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.